09:46 AM EST - TSO3 Inc. : announced that the company has received clearance from the U.S. Food and Drug Administration to expand the intended use claims for its TSO3 STERIZONE 125L Sterilizer. These new claims include the sterilization of packaged, multi-channel flexible endoscopes, such as colonoscopes, gastroscopes, bronchoscopes, ureteroscopes and choledochoscopes. Earlier in 2009, TSO3 outlined its plans to; increase the utility of its sterilizer though the creation of new cycles; develop relationships leading to a channel partner and increase market opportunities via expansion outside of North America. TSO3 Inc.
shares T.TOS are trading up $0.18 at $1.60.
